2023
DOI: 10.1016/j.ebiom.2023.104555
|View full text |Cite
|
Sign up to set email alerts
|

Macrophage CD5L is a target for cancer immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 57 publications
1
3
0
Order By: Relevance
“… 51 In a study of lung adenocarcinoma, the immunosuppressive phenotype of macrophages was blocked in vitro by an anti-CD5L monoclonal antibody. 52 In our study, CD5L expression was significantly reduced in HCC tissues and correlated with the expression of TBX21 and EOMES, suggesting that CD5L may be involved in regulating Tex. Alongside complement proteins such as C5b, C6, C8, and C9, C7 forms part of the membrane attack complex (MAC).…”
Section: Discussionsupporting
confidence: 57%
“… 51 In a study of lung adenocarcinoma, the immunosuppressive phenotype of macrophages was blocked in vitro by an anti-CD5L monoclonal antibody. 52 In our study, CD5L expression was significantly reduced in HCC tissues and correlated with the expression of TBX21 and EOMES, suggesting that CD5L may be involved in regulating Tex. Alongside complement proteins such as C5b, C6, C8, and C9, C7 forms part of the membrane attack complex (MAC).…”
Section: Discussionsupporting
confidence: 57%
“…In general, the key to cancer metastasis is migration and invasion, and the TME plays an important role in these processes. For example, TAMs with high CD5L expression have been shown to be associated with poor prognosis in patients with papillary lung adenocarcinoma [45], and subtypes of high-grade serous ovarian cancer macrophages have been revealed to be associated with the prognosis of tumor extracellular matrix signatures [46]. Moreover, analysis of the TME in metastatic breast cancer identified several tumor-promoting genes in bone marrow cells and confirmed diversity in CAFs, endothelial cells, and mural cells [47].…”
Section: Discussionmentioning
confidence: 95%
“…Macrophages are implicated in many cancers, including mesothelioma and lung cancer [56,84,[125][126][127][128] , where they can make up to half of the total tumour burden [125,[129][130][131] . Indeed, tumour-associated macrophage (TAM) numbers are often associated with poorer outcome [132][133][134] due to their ability to promote tumour growth [59,125,135] , invasion, metastasis [132,136] , neoangiogenesis [51,59,71] and therapeutic resistance [137][138][139] .…”
Section: Tumour-associated Macrophagesmentioning
confidence: 99%